Plasma copeptin and the risk of diabetes mellitus (Q37147707)

18 August 2017

Plasma copeptin and the risk of diabetes mellitus (English)

1 reference

18 August 2017

13

Marju Orho-Melander

1 reference

18 August 2017

Christopher Newton-Cheh

14

object named as

Christopher Newton-Cheh

1 reference

18 August 2017

Eero Lindholm

10

0 references

Olle Melander

15

object named as

Olle Melander

1 reference

18 August 2017

11

Leif Groop

1 reference

18 August 2017

4

Peter Almgren

1 reference

18 August 2017

6

Göran Berglund

1 reference

18 August 2017

7

Joachim Struck

1 reference

18 August 2017

8

Nils G Morgenthaler

1 reference

18 August 2017

2

Thomas J Wang

1 reference

18 August 2017

1

Sofia Enhörning

1 reference

18 August 2017

Peter M Nilsson

3

1 reference

18 August 2017

Bo Hedblad

5

1 reference

18 August 2017

Andreas Bergmann

9

1 reference

18 August 2017

Valeria Lyssenko

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

3 May 2010

1 reference

18 August 2017

1 reference

18 August 2017

121

1 reference

18 August 2017

2102-2108

1 reference

18 August 2017

19

1 reference

Incremental value of copeptin for rapid rule out of acute myocardial infarction

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Copeptin in the differential diagnosis of hyponatremia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Management of inherited von Willebrand disease in 2007.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Science review: Vasopressin and the cardiovascular system part 1--receptor physiology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Cloning and characterization of the human V3 pituitary vasopressin receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Plasma Vasopressin in Uncontrolled Diabetes Mellitus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Pancreatic vasopressin V1breceptors: characterization in In-R1-G9 cells and localization in human pancreas

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Mechanism of vasopressin-induced platelet aggregation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Insulin hypersensitivity in mice lacking the V1b vasopressin receptor.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Plasma Adiponectin Levels in Relation to Carotid Intima Media Thickness and Markers of Insulin Resistance

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763235

Classifying diabetes according to the new WHO clinical stages

4 December 2018

1 reference

12 December 2020

The effect of vasopressin infusion on glucose metabolism in man

1 reference

12 December 2020

The Malmo Diet and Cancer Study. Design and feasibility

1 reference

12 December 2020

Comment on the provisional report from the WHO consultation

1 reference

12 December 2020

Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.109.909663

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference